N6-Alkyl-2-alkynyl Derivatives of Adenosine as Potent and Selective Agonists at the Human Adenosine A3Receptor and a Starting Point for Searching A2BLigands
| Autor: | Stefano Costanzi, Karl-Norbert Klotz, Rosaria Volpini, Gloria Cristalli, Catia Lambertucci, Sara Taffi, Sauro Vittori |
|---|---|
| Rok vydání: | 2002 |
| Předmět: |
Agonist
Adenosine Magnetic Resonance Spectroscopy Receptor Adenosine A2A medicine.drug_class Stereochemistry CHO Cells Ligands Receptor Adenosine A2B Chemical synthesis Structure-Activity Relationship Cricetinae Drug Discovery Purinergic P1 Receptor Agonists medicine Animals Humans Potency Receptor Adenosine A3 Receptor Agonists Chemistry Receptor Adenosine A3 Receptors Purinergic P1 Stereoisomerism Ribonucleoside Recombinant Proteins In vitro Alkynes Molecular Medicine Adenylyl Cyclases medicine.drug |
| Zdroj: | Journal of Medicinal Chemistry. 45:3271-3279 |
| ISSN: | 1520-4804 0022-2623 |
| DOI: | 10.1021/jm0109762 |
| Popis: | A series of N(6)-alkyl-2-alkynyl derivatives of adenosine (Ado) have been synthesized and evaluated for their affinity at human A(1), A(2A), and A(3) receptors and for their potency at A(2B) adenosine receptor subtypes. The corresponding 2-(1-alkynyl) derivatives of 5'-N-ethylcarboxamidoadenosine (NECA) and Ado are used as reference compounds. Binding studies demonstrated that the activities of 2-alkynylAdos were slightly increased for the adenosine A(1) receptor and slightly decreased for both A(3) and A(2B) subtypes compared to those of their corresponding NECA derivatives, whereas the A(2A) receptor affinities of the two series of nucleosides were similar. The presence of a methyl group on N(6) of the 2-alkynyladenosines, inducing an increase in affinity at the human A(3) receptor and a decrease at the other subtypes, resulted in an increase in A(3) selectivity. In particular, 2-phenylethynyl-N(6)-methylAdo (8b) showed an A(3) affinity in the low nanomolar range (K(i)(A(3)) = 3.4 nM), with a A(1)/A(3) and A(2A)/A(3) selectivity of about 500 and 2500, respectively. These findings motivated us to search for the preparation of new selective radioligands for the A(3) subtype; hence, a procedure to introduce a tritiated alkylamino group in these molecules was carried out. As far as the potency at the A(2B) receptor, the type of 2-alkynyl chain and the presence of the ethylcarboxamido group on the sugar seem to be very important; in fact, the (S)-2-phenylhydroxypropynylNECA [(S)-PHPNECA, 1e, EC(50)(A(2B)) = 0.22 microM] proved to be one of the most potent A(2B) agonist reported so far. On the other hand, the (S)-2-phenylhydroxypropynyl-N(6)-ethylAdo (9e, EC(50)(A(2B)) = 0.73 microM) showed a significantly increase of potency at the A(2B) subtype in comparison with the N(6)-methyl, N(6)-isopropyl, and the unsubstituted adenosine derivatives, although it resulted in being less potent than (S)-PHPNECA (1e, EC(50)(A(2B)) = 0.22 microM). These observations suggest that the introduction of an ethyl group in the N(6)-position and an ethylcarboxamido substituent in the 4'-position of (S)-2-phenylhydroxypropynyladenosine could lead to a compound endowed with high potency at the A(2B) receptor. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|